Eurofins Scientific SEFRA:ESF0 +3.31%87 Future 3-5Y Total Revenue Growth Rate is 5.76 as of Jun. 24, 2026. GuruFocus rates FRA:ESF0 with a GF Score™ of 87/100 and a GF Value™ of €66.54 (Fairly Valued). The stock has 6 warning signs investors should review. Among 85 Medical Diagnostics & Research companies, Eurofins Scientific SE ranks worse than 78.82% on this metric.
Future 3-5Y Total Revenue Growth Rate is the average growth rate of total revenue estimates over a 3-year to 5-year period.
Eurofins Scientific SE (FRA:ESF0) Future 3-5Y Total Revenue Growth Rate Explanation
Future 3-5Y Total Revenue Growth Rate is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.
In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.
Eurofins Scientific SE Future 3-5Y Total Revenue Growth Rate Related Terms
FRA:ESF0 vs TMO, DHR, IDXX: Future 3-5Y Total Revenue Growth Rate Comparison
For the Diagnostics & Research subindustry, Eurofins Scientific SE's Future 3-5Y Total Revenue Growth Rate, along with its competitors' market caps and Future 3-5Y Total Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eurofins Scientific SE Future 3-5Y Total Revenue Growth Rate vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Eurofins Scientific SE's Future 3-5Y Total Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Eurofins Scientific SE's Future 3-5Y Total Revenue Growth Rate falls into.
What does a Future 3-5Y Total Revenue Growth Rate of 5.76 mean?
Eurofins Scientific SE (FRA:ESF0) has a Future 3-5Y Total Revenue Growth Rate of 5.76 as of Jun. 24, 2026. Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period. View historical data for Eurofins Scientific SE and its competitors. According to the industry distribution chart, Eurofins Scientific SE ranks #67 out of 85 companies in the Medical Diagnostics & Research industry, placing it in the top 78.8%.
Is Eurofins Scientific SE's Future 3-5Y Total Revenue Growth Rate too high?
Eurofins Scientific SE's current Future 3-5Y Total Revenue Growth Rate is 5.76. The Medical Diagnostics & Research industry median Future 3-5Y Total Revenue Growth Rate is 10.64. Eurofins Scientific SE's value of 5.76 is 45.9% below this industry median. Based on the distribution chart, Eurofins Scientific SE ranks #67 out of 85 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Eurofins Scientific SE has a GF Score™ of 87/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's Future 3-5Y Total Revenue Growth Rate compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Eurofins Scientific SE ranks #67 out of 85 companies for Future 3-5Y Total Revenue Growth Rate. This places Eurofins Scientific SE in the lower half of its industry. The industry median Future 3-5Y Total Revenue Growth Rate is 10.64. Eurofins Scientific SE's value of 5.76 is 45.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y Total Revenue Growth Rate for a Medical Diagnostics & Research company?
The median Future 3-5Y Total Revenue Growth Rate among Medical Diagnostics & Research companies is 10.64, based on 85 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y Total Revenue Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y Total Revenue Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eurofins Scientific SE's current Future 3-5Y Total Revenue Growth Rate of 5.76 is 45.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y Total Revenue Growth Rate mean?
A high Future 3-5Y Total Revenue Growth Rate can signal that a stock is expensive relative to its fundamentals. Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period. View historical data for Eurofins Scientific SE and its competitors. For the Medical Diagnostics & Research industry, the median Future 3-5Y Total Revenue Growth Rate is 10.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eurofins Scientific SE's current Future 3-5Y Total Revenue Growth Rate is 5.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (FRA:ESF0) is currently considered Fairly Valued. The stock's GF Value™ is €66.54, compared to a current price of €64.88 — trading 2.5% below its estimated fair value. The current Future 3-5Y Total Revenue Growth Rate is 5.76 and 45.9% below the Medical Diagnostics & Research industry median of 10.64. Eurofins Scientific SE's overall GF Score™ is 87/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y Total Revenue Growth Rate calculated?
Future 3-5Y Total Revenue Growth Rate is calculated from a company's financial statements. For Eurofins Scientific SE (FRA:ESF0), the current Future 3-5Y Total Revenue Growth Rate is 5.76 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eurofins Scientific SE (FRA:ESF0) Overvalued in 2026?
Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be undervalued.
The current stock price of €64.88 is trading 2.5% below its estimated GF Value™ of €66.54.
GuruFocus considers Eurofins Scientific SE to be Fairly Valued.
Key valuation signals for FRA:ESF0:
Future 3-5Y Total Revenue Growth Rate: 5.76
GF Value™: €66.54 vs. price of €64.88 (2.5% below fair value)
Industry Position: 45.9% below the Medical Diagnostics & Research median (#67 of 85)
No single metric tells the full story. See the FRA:ESF0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
87GF Score
Get the complete analysis for FRA:ESF0
Future 3-5Y Total Revenue Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ESF0 has been successfully added to your 